Health
GSK says long-acting HIV prevention drug 66% more effective than Truvada – WHTC News
(Reuters) – Britain’s GSK said on Tuesday that an injection of its cabotegravir drug given every two months was found to be 66% more effective in preventing HIV infections than Gilead’s Truvada daily oral pills.
HIV incidence rate – or the number of people wh…
(Reuters) – Britain’s GSK said on Tuesday that an injection of its cabotegravir drug given every two months was found to be 66% more effective in preventing HIV infections than Gilead’s Truvada daily…
-
General21 hours agoLanlan Yang pleads not guilty over Rolls-Royce crash in Sydney
-
Business20 hours agoBuying Coles shares? Here’s the dividend yield after the 8% price drop
-
Noosa News21 hours agoBrett Andrew Button appeal: Hunter Valley wedding bus crash driver loses fight to reduce sentence
-
General14 hours agoMore than 11,000 homes lose power as storms with spectacular lightning hit south-east Queensland